MITRIS RESILIA Mitral Valve
Device Pericardial Heart Valves
PDI 00690103205558
General payments
$843,353
Research payments
$2,306
Through program year 2025, $843,353 in general payments and $2,306 in research payments were reported against MITRIS RESILIA Mitral Valve (Pericardial Heart Valves).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $272,046 | 2,619 |
| 2025 | Research | $2,306 | 4 |
| 2024 | General | $242,354 | 2,461 |
| 2023 | General | $191,526 | 2,223 |
| 2022 | General | $137,428 | 2,166 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 36 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
9,469 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.